KORU Medical Systems, Inc. announced a development agreement with a biopharmaceutical manufacturer for KORU Medical to develop and seek regulatory approval for a next-generation infusion system for its subcutaneous immunoglobulin (SCIg) therapy.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | -1.35% | -6.78% | -10.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.39% | 102M | |
-5.51% | 182B | |
-0.58% | 114B | |
-5.76% | 67.76B | |
+1.29% | 51.91B | |
+7.18% | 43.23B | |
+6.07% | 41.07B | |
+21.70% | 32.07B | |
+15.86% | 25B | |
-4.28% | 24.55B |
- Stock Market
- Equities
- KRMD Stock
- News KORU Medical Systems, Inc.
- KORU Medical Systems, Inc. Announces Development Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System